Osimertinib study in Indian Patients

Trial Identifier: D5161C00005
Sponsor: AstraZeneca
NCTID:: NCT03853551
Start Date: April 2019
Primary Completion Date: April 2020
Condition: Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
India Hyderabad, India, 500096
India Hyderabad, India, 500034
India Kolkata, India, 700160
India Mumbai, India, 400053
India Mumbai, India, 400012
India New Dehli, India, 110029
India New Delhi, India, 110060
India New Delhi, India, 110085